Cargando…

Therapy of Osteoporosis in Men with Teriparatide

Osteoanabolic therapy is an attractive therapeutic option for men with osteoporosis because it directly stimulates bone formation, an action not shared by any antiresorptive drug. Teriparatide (recombinant human PTH(1-34)) and PTH(1-84) are available in many countries but PTH(1-84) is not available...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cusano, Natalie E., Costa, Aline G., Silva, Barbara C., Bilezikian, John P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205768/ https://www.ncbi.nlm.nih.gov/pubmed/22132345 http://dx.doi.org/10.4061/2011/463675

Ejemplares similares

Teriparatide in the management of osteoporosis
por: Bodenner, Donald, et al.
Publicado: (2007)

Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment
por: Gagnon, Claudia, et al.
Publicado: (2008)

Teriparatide – Indications beyond osteoporosis
por: Cheng, Marilyn Lee, et al.
Publicado: (2012)

Male osteoporosis
por: Bandeira, Leonardo, et al.
Publicado: (2022)

New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide
por: Tanaka, Sakae, et al.
Publicado: (2014)

Profile of teriparatide in the management of postmenopausal osteoporosis
por: Sikon, Andrea, et al.
Publicado: (2010)

Teriparatide for osteoporosis: importance of the full course
por: Lindsay, R., et al.
Publicado: (2016)

Treatment of osteoporosis with teriparatide: The Slovenian experience
por: Kocjan, Tomaz, et al.
Publicado: (2021)

Management of glucocorticoids-induced osteoporosis: role of teriparatide
por: Migliaccio, Silvia, et al.
Publicado: (2009)

Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
por: Lau, Arthur N, et al.
Publicado: (2010)

Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
por: Minisola, Salvatore, et al.
Publicado: (2019)

Treatment responses with once-weekly teriparatide therapy for osteoporosis
por: Shiraki, M., et al.
Publicado: (2016)

Long-term consequences of osteoporosis therapy with denosumab
por: Bandeira, Francisco, et al.
Publicado: (2022)

PINP as a biological response marker during teriparatide treatment for osteoporosis
por: Krege, J. H., et al.
Publicado: (2014)

Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis
por: Farahmand, P., et al.
Publicado: (2013)

Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups
por: Hauser, Barbara, et al.
Publicado: (2021)

A Case of Teriparatide on Pregnancy-Induced Osteoporosis
por: Lee, Seok Hong, et al.
Publicado: (2013)

Utility of radius bone densitometry for the treatment of osteoporosis with once-weekly teriparatide therapy
por: Nakayama, Harumi, et al.
Publicado: (2018)

Recombinant PTH: A Study of the Outcome of Teriparatide Therapy for 138 Patients with Osteoporosis
por: McNeilly, Thomas, et al.
Publicado: (2013)

Comparative Effects of Teriparatide and Risedronate in Glucocorticoid-Induced Osteoporosis in Men: 18-Month Results of the EuroGIOPs Trial
por: Glüer, Claus-C, et al.
Publicado: (2013)

Dilemmas in the diagnosis and management of osteoporosis in a patient with alkaptonuria: Successful treatment with teriparatide
por: Ebrahim, Ismail C., et al.
Publicado: (2022)

Controversies in the treatment of postmenopausal osteoporosis: How long to treat with bisphosphonates?
por: Bandeira, Francisco, et al.
Publicado: (2020)

Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosis
por: Dore, Robin K
Publicado: (2013)

Synthesis and anti-osteoporosis activity of novel Teriparatide glycosylation derivatives
por: Wang, Nan, et al.
Publicado: (2020)

Weekly Teriparatide Therapy Rapidly Accelerates Bone Healing in Pyogenic Spondylitis with Severe Osteoporosis
por: Shinohara, Akira, et al.
Publicado: (2014)

Impact of teriparatide therapy in Indian postmenopausal women with osteoporosis with regard to DXA-derived parameters
por: Sandeep, Nandipati Venkata, et al.
Publicado: (2022)

Improvement in health-related quality of life in osteoporosis patients treated with teriparatide
por: Lau, Arthur N, et al.
Publicado: (2008)

Teriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis
por: Taheri, Saeed, et al.
Publicado: (2019)

Changes observed in radionuclide bone scans during and after teriparatide treatment for osteoporosis
por: Moore, Amelia E. B., et al.
Publicado: (2011)

Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide
por: Gupta, Vishal
Publicado: (2013)

Effects of teriparatide in Chinese and Caucasian women with osteoporosis: bridging study on efficacy
por: Xie, Zhongjian, et al.
Publicado: (2019)

THU441 Teriparatide As Treatment For Severe Osteoporosis In Lung Transplant Recipients
por: Muir, Christopher Alan, et al.
Publicado: (2023)

Combined treatment of vitamin K and teriparatide on bone metabolism and biomechanics in rats with osteoporosis
por: Huang, Youqing
Publicado: (2018)

Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis
por: Bonafede, M. M., et al.
Publicado: (2015)

Efficacy of the Combination of Teriparatide and Denosumab in the Treatment of Postmenopausal Osteoporosis: A Meta-Analysis
por: Sun, Yang, et al.
Publicado: (2022)

A Bone Histomorphometric Analysis of Hypophosphatasia-related Osteoporosis after Teriparatide Treatment
por: Mizuno, Hiroki, et al.
Publicado: (2022)

Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study
por: Lu, Chunyan, et al.
Publicado: (2017)

Pharmacokinetics of Teriparatide (rhPTH[1–34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis
por: Satterwhite, Julie, et al.
Publicado: (2010)

Effects of denosumab versus teriparatide in glucocorticoid-induced osteoporosis patients with prior bisphosphonate treatment
por: Hirooka, Yasuaki, et al.
Publicado: (2020)

PSAT182 Dilemmas in the Diagnosis and Management of Osteoporosis in a patient with Alkaptonuria: Successful Treatment with Teriparatide
por: Ebrahim, Ismail, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_auoq127rosgrbkbg2qk8paf6f5